Prim, S.A. (BME:PRM)
12.65
-0.10 (-0.78%)
Sep 12, 2025, 5:35 PM CET
Prim, S.A. Revenue
Prim, S.A. had revenue of 113.67M EUR in the half year ending December 31, 2024, with 15.49% growth. This brings the company's revenue in the last twelve months to 240.65M, up 5.20% year-over-year. In the year 2024, Prim, S.A. had annual revenue of 233.36M with 7.73% growth.
Revenue (ttm)
240.65M
Revenue Growth
+5.20%
P/S Ratio
0.89
Revenue / Employee
251.21K
Employees
958
Market Cap
215.22M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 233.36M | 16.74M | 7.73% |
Dec 31, 2023 | 216.62M | 19.22M | 9.74% |
Dec 31, 2022 | 197.40M | 28.82M | 17.10% |
Dec 31, 2021 | 168.57M | 21.16M | 14.35% |
Dec 31, 2020 | 147.41M | -3.66M | -2.42% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grifols | 7.45B |
Laboratorios Farmaceuticos Rovi | 749.00M |
Almirall | 1.05B |
Pharma Mar | 189.27M |
Faes Farma | 543.77M |
Clínica Baviera | 288.92M |
Laboratorio Reig Jofre | 336.87M |
Atrys Health | 218.10M |